Evidence map›Paper›PMID 34270708›Full record

ArticleHuman molecular genetics2021

Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy.

Melanie Gartz, Margaret Beatka, Mariah J Prom, Jennifer L Strande, Michael W Lawlor

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. MicroRNAs in Dystrophinopathy.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Melanie GartzDepartment of Cell Biology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.ORCID 0000-0001-8117-0906
Margaret BeatkaNeuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Mariah J PromNeuroscience Research Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Jennifer L StrandeDepartment of Cell Biology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Michael W LawlorDepartment of Cell Biology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Medical College of Wisconsin · US

Funding

Developing nicorandil and companion biomarkers for DMD cardiomyopathy therapyR01HL134932 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LAWLOR, MICHAEL WILLIAM · 2017 to 2020
$1.8M
iPSC-derived cardiomyocytes to study dystrophic cardiomyopathyK08HL111148 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI STRANDE, JENNIFER LYNN · 2012 to 2016
$670k
NHLBI NIH HHS K08 HL111148NHLBI NIH HHS R01 HL134932
6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is an X-linked genetic disease characterized by severe, progressive muscle wasting. Cardiomyopathy has emerged as a leading cause of death in patients with DMD. The mechanisms contributing to DMD cardiac disease remain under investigation and specific therapies available are lacking. Our prior work has shown that DMD-iPSC-derived cardiomyocytes (DMD-iCMs) are vulnerable to oxidative stress injury and chronic exposure to DMD-secreted exosomes impaired the cell's ability to protect against stress. In this study, we sought to examine a mechanism by which DMD cardiac exosomes impair cellular response through altering important stress-responsive genes in the recipient cells. Here, we report that DMD-iCMs secrete exosomes containing altered microRNA (miR) profiles in comparison to healthy controls. In particular, miR-339-5p was upregulated in DMD-iCMs, DMD exosomes and mdx mouse cardiac tissue. Restoring dystrophin in DMD-iCMs improved the cellular response to stress and was associated with downregulation of miR-339-5p, suggesting that it is disease-specific. Knockdown of miR-339-5p was associated with increased expression of MDM2, GSK3A and MAP2K3, which are genes involved in important stress-responsive signaling pathways. Finally, knockdown of miR-339-5p led to mitochondrial protection and a reduction in cell death in DMD-iCMs, indicating miR-339-5p is involved in direct modulation of stress-responsiveness. Together, these findings identify a potential mechanism by which exosomal miR-339-5p may be modulating cell signaling pathways that are important for robust stress responses. Additionally, these exosomal miRs may provide important disease-specific targets for future therapeutic advancements for the management and diagnosis of DMD cardiomyopathy.

Indexed as

BiomarkersCardiomyopathiesDisease SusceptibilityDystrophinExosomesGene Expression RegulationGene Knockdown TechniquesHumansMicroRNAsMuscle, SkeletalMuscular Dystrophy, DuchenneMyocytes, CardiacStress, PhysiologicalBiomarkersDMD protein, humanDystrophinMicroRNAsMIRN339 microRNA, human

Identifiers

PMID34270708
PMCPMC8600005
OpenAlexW3177805797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.